The best indicator for Lockheed Martin (LMT)
We backtested 20 indicators across daily, weekly and hourly charts on real Lockheed Martin (LMT) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
EMA 20/50 Cross
On the weekly chart, this is the strongest risk-adjusted edge we found for Lockheed Martin (LMT) over ~64.7 years — trailing buy-and-hold by 2.6% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | EMA 20/50 Cross ✓ | Weekly | 7.9% | 0.42 | -60.8% | 44.8% | 29 | -2.6% |
| 2 | EMA-10 Trend ✓ | Weekly | 7.0% | 0.4 | -59.3% | 45.3% | 300 | -3.5% |
| 3 | Donchian Breakout ✓ | Weekly | 6.2% | 0.39 | -71.4% | 46.9% | 49 | -4.4% |
| 4 | RSI Trend (>50) ✓ | Weekly | 6.6% | 0.38 | -77.7% | 41.0% | 166 | -3.9% |
| 5 | EMA 50/200 Cross ✓ | Daily | 6.3% | 0.37 | -79.6% | 36.4% | 44 | -4.3% |
| 6 | RSI Trend (>50) ✓ | Daily | 6.2% | 0.37 | -71.1% | 35.2% | 897 | -4.4% |
| 7 | Donchian Midline ✓ | Weekly | 6.2% | 0.37 | -78.4% | 45.9% | 172 | -4.4% |
| 8 | SMA 50/200 Cross ✓ | Daily | 6.0% | 0.36 | -64.3% | 41.3% | 46 | -4.6% |
| 9 | EMA 20/50 Cross ✓ | Daily | 6.0% | 0.36 | -77.6% | 37.4% | 155 | -4.6% |
| 10 | WaveTrend (8/6/4) ✓ | Weekly | 5.8% | 0.36 | -88.9% | 81.6% | 49 | -4.8% |
| 11 | Donchian Breakout ✓ | Daily | 5.4% | 0.35 | -72.9% | 42.5% | 254 | -5.1% |
| 12 | Stochastic ✓ | Daily | 4.5% | 0.31 | -78.9% | 68.3% | 322 | -6.0% |
| 13 | Money Flow Index ✓ | Daily | 4.7% | 0.31 | -85.6% | 72.8% | 81 | -5.8% |
| 14 | Donchian Midline ✓ | Daily | 4.7% | 0.31 | -76.3% | 37.3% | 891 | -5.8% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Lockheed Martin (LMT), EMA 20/50 Cross on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.